Randomized controlled trial of rosiglitazone in the treatment of LADA patients.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Latent autoimmune diabetes in adults; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Nov 2011 Status changed from completed to recruiting as reported by Chinese Clinical Trial Register record.
- 03 Oct 2009 New trial record